Ongoing Trials | csar-resuscitation

Ongoing Clinical Trials

At CSAR, our mission is to provide evidence-based clinical trials for the health of our community. We strive to contribute to the advancement of medical research and the understanding of human health. Our team of scientists and researchers are committed to delivering the highest quality of care with the utmost integrity.

CSAR is dedicated to providing our patients with the most innovative and reliable medical treatments. Our clinical trials are evidence-based and designed to provide patients with the best possible outcomes. We invite you to join us in our mission to improve the health of our community.

The PLaNT-Trial: Prophylactic CPAP to Optimize Outcomes in Spontaneously Breathing Late Preterm Infant Born by C-Section

The VERSE - Trial: Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation

The PLUSS+S - Trial: Does administration of intra-tracheal budesonide during the early treatment of respiratory distress syndrome (RDS) in extremely preterm infants increase survival without bronchopulmonary dysplasia (BPD) at 36 weeks’ postmenstrual age (PMA)?

The HiLo - Trial: 30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants

The NOVEL - Trial: High continuous positive airway pressures versus non-invasive positive pressure ventilation in preterm neonates: protocol for a multicentre pilot randomised controlled trial